4.84MMarket Cap-860P/E (TTM)
0.663High0.636Low10.83KVolume0.663Open0.643Pre Close7.02KTurnover0.23%Turnover RatioLossP/E (Static)7.61MShares2.71052wk High1.89P/B3.06MFloat Cap0.60152wk Low--Dividend TTM4.80MShs Float7.720Historical High--Div YieldTTM4.12%Amplitude0.601Historical Low0.648Avg Price1Lot Size
Lipella Pharmaceuticals Stock Forum
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
PITTSBURGH, May 31, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first Site Initiation Visit (SIV) for the Phase 2a trial evalua...
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
3 MINUTES AGO, 8:00 AM EST
VIA GLOBENEWSWIRE
$Lipella Pharmaceuticals(LIPO.US)$
double bottom?
$XBP Europe Holdings(XBP.US)$
$Volato Group(SOAR.US)$
$Meiwu Technology(WNW.US)$
$Lipella Pharmaceuticals(LIPO.US)$ Lipella
No comment yet